ASX - Delayed Quote AUD

Beamtree Holdings Limited (BMT.AX)

0.2600
-0.0100
(-3.70%)
At close: May 9 at 1:52:22 PM GMT+10
Loading Chart for BMT.AX
  • Previous Close 0.2700
  • Open 0.2600
  • Bid 0.2450 x --
  • Ask 0.2650 x --
  • Day's Range 0.2600 - 0.2650
  • 52 Week Range 0.1750 - 0.3800
  • Volume 103,404
  • Avg. Volume 131,254
  • Market Cap (intraday) 75.35M
  • Beta (5Y Monthly) 1.74
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.70

Beamtree Holdings Limited provides artificial intelligence-based decision support software and data insight services to healthcare industry in Australia and internationally. It operates through four segments: Diagnostic Technology; Clinical Decision Support; Coding Assistance and Data Quality; and Analytics and Knowledge Networks. The company offers RippleDown Expert, a CDS system that provides treatment recommendations, real-time alerts, and advanced reflex and appropriate testing recommendations; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a quality assessment tool for clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; and Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing. In addition, the company offers advisory and auditing solution, such as desktop analysis, data maturity index, and physical audits. The company was formerly known as PKS Holdings Limited and changed its name to Beamtree Holdings Limited in August 2021. The company was founded in 1996 and is headquartered in North Sydney, Australia.

beamtree.com.au

97

Full Time Employees

June 30

Fiscal Year Ends

Recent News: BMT.AX

View More

Performance Overview: BMT.AX

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

BMT.AX
5.45%
S&P/ASX 200 [XJO] (^AXJO)
0.88%

1-Year Return

BMT.AX
15.56%
S&P/ASX 200 [XJO] (^AXJO)
6.60%

3-Year Return

BMT.AX
1.96%
S&P/ASX 200 [XJO] (^AXJO)
15.60%

5-Year Return

BMT.AX
73.33%
S&P/ASX 200 [XJO] (^AXJO)
52.68%

Compare To: BMT.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BMT.AX

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    78.25M

  • Enterprise Value

    75.59M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    1.77

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -18.87%

  • Return on Assets (ttm)

    -6.03%

  • Return on Equity (ttm)

    -11.80%

  • Revenue (ttm)

    28.89M

  • Net Income Avi to Common (ttm)

    -5.45M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.89M

  • Total Debt/Equity (mrq)

    3.53%

  • Levered Free Cash Flow (ttm)

    871.75k

Research Analysis: BMT.AX

View More

Company Insights: BMT.AX

Research Reports: BMT.AX

View More

People Also Watch